These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3367384)

  • 1. Modification of the hypoxic fraction of a xenografted human colon tumor by differentiation-inducing agents.
    Leith JT
    J Natl Cancer Inst; 1988 May; 80(6):444-7. PubMed ID: 3367384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the differentiating agents sodium butyrate and N-methylformamide on the oxygen enhancement ratio of human colon tumor cells.
    Hallows KR; Bliven SF; Leith JT
    Radiat Res; 1988 Jan; 113(1):191-8. PubMed ID: 3340722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxic fractions in xenografted human colon tumors.
    Leith JT; Padfield G; Faulkner L; Michelson S
    Cancer Res; 1991 Oct; 51(19):5139-43. PubMed ID: 1913639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by N-methylformamide of the effect of ionizing radiation on a human colon tumor xenografted in nude mice.
    Dexter DL; Lee ES; Bliven SF; Glicksman AS; Leith JT
    Cancer Res; 1984 Nov; 44(11):4942-6. PubMed ID: 6488157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of in vitro cytotoxic effects of misonidazole on human colon tumor cells by the differentiation-inducing agent N-methylformamide.
    Arundel CM; Leith JT; Lee ES; Leite DV; Glicksman AS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1429-32. PubMed ID: 3759567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the volumetric growth responses and steady-state hypoxic fractions of xenografted DLD-2 human colon carcinomas by administration of basic fibroblast growth factor or suramin.
    Leith JT; Papa G; Quaranto L; Michelson S
    Br J Cancer; 1992 Aug; 66(2):345-8. PubMed ID: 1503909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of partial hepatectomy on the growth characteristics and hypoxic fractions of xenografted DLD-2 human colon cancers.
    Leith JT; Padfield G; Michelson S
    Radiat Res; 1992 Nov; 132(2):263-8. PubMed ID: 1438710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of radiation injury in human colon tumor cells by the maturational agent sodium butyrate (NaB).
    Arundel CM; Glicksman AS; Leith JT
    Radiat Res; 1985 Dec; 104(3):443-8. PubMed ID: 4080986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vitro and in vivo. A preliminary note.
    Otaka M; Singhal A; Hakomori S
    Biochem Biophys Res Commun; 1989 Jan; 158(1):202-8. PubMed ID: 2912449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of polar organic compounds on gynecologic cancers.
    Kan YY; Ng HT; Chao KC; Ho DM; Wong H; Cheung YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Sep; 42(3):175-84. PubMed ID: 3224317
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the growth of human colon cancer xenografts by polar solvents.
    Dexter DL; Spremulli EN; Matook GM; Diamond I; Calabresi P
    Cancer Res; 1982 Dec; 42(12):5018-22. PubMed ID: 7139607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of doxorubicin resistance in heterogeneous human colon tumor cells by N-methylformamide.
    Ferrari LA; Bliven SF; Wiemann M; Calabresi P; Glicksman AS; Leith JT
    Cancer Treat Rep; 1986 Oct; 70(10):1177-80. PubMed ID: 3756940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents.
    Leith JT; Lee ES; Leite DV; Glicksman AS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1423-7. PubMed ID: 2428792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of autophagy and PPARγ protect colon cancer cells against apoptosis induced by interactive effects of butyrate and DHA in a cell type-dependent manner: The role of cell differentiation.
    Tylichová Z; Straková N; Vondráček J; Vaculová AH; Kozubík A; Hofmanová J
    J Nutr Biochem; 2017 Jan; 39():145-155. PubMed ID: 27840291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in hypoxic fraction of human colon tumor xenografts by preirradiation of tumor bed.
    Leith JT
    NCI Monogr; 1988; (6):107-9. PubMed ID: 3352751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of carcinoembryonic antigen release by HT-29 colon carcinoma line in the presence of different agents.
    Friedman J; Seger M; Levinsky H; Allalouf D
    Experientia; 1987 Oct; 43(10):1121-2. PubMed ID: 2444456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate and colonic cytokinetics: differences between in vitro and in vivo studies.
    Lupton JR
    Eur J Cancer Prev; 1995 Oct; 4(5):373-8. PubMed ID: 7496326
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the tyrosine kinase activity with the proliferation rate in human colon solid tumors and tumor cell lines.
    Kéri G; Balogh A; Teplán I; Csuka O
    Tumour Biol; 1988; 9(6):315-22. PubMed ID: 3206110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in X-ray sensitivity and glutathione content of human colon tumor cells after exposure to the differentiation-inducing agent sodium butyrate.
    Leith JT; Hallows KT; Arundel CM; Bliven SF
    Radiat Res; 1988 Jun; 114(3):579-88. PubMed ID: 3375444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
    Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
    Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.